Gnrh Antagonists News Today

Alicia Morgans, MD, MPH, discusses androgen deprivation therapy and its role in treating prostate cancer.

A urologic oncology fellow provides a comprehensive overview of systemic therapy options for patients with prostate cancer.

Although the disease afflicts at least 1 out of every 10 women, endometriosis remains a conundrum for patients and their physicians.

Linzagolix is an oral gonadotropin-releasing hormone antagonist for the management of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.